Meet PHAZE, the Contract Research Organization leading ThrombUS+'s clinical validation across Greece, Italy, France, and Lithuania, from ethics approval to GCP-compliant multi-site coordination.
Yearly Archives: 2026
7 posts
Recap of the first ThrombUS+ scientific conference on DVT detection, held at Papageorgiou General Hospital in Thessaloniki, featuring a live prototype demonstration.
MEDEA S.r.l. is the ThrombUS+ partner leading exploitation strategy, IP management, and impact assurance to bring AI-powered DVT monitoring technology to market.
Meet VDE, ThrombUS+'s regulatory partner. Learn how VDE is embedding compliance-by-design into the development of an AI-powered wearable for early DVT detection.
Hôpital Simone Veil, the only French partner in ThrombUS+, brings cutting-edge venous thrombosis research and emergency medicine expertise to the consortium.
How do you build an AI medical device that meets EU MDR and AI Act requirements? Regulatory expert Thorsten Prinz of ThrombUS+ partner VDE explains the roadmap to compliance.
Founded by Saint Pio in 1956, Casa Sollievo della Sofferenza combines compassionate care and scientific excellence. Now a leading Italian Research Hospital (IRCCS), it contributes specialized expertise in pregnancy-related thrombosis to the ThrombUS+ European Project.